Temasek is a Singaporean state-owned global investment company incorporated in 1974 under the Singapore Companies Act to own and commercially manage investments and assets. It invests across a broad range of sectors including financial services, telecommunications, media, technology, consumer goods, life sciences, and agri-food, with a strategic focus on growth and late-stage investments.
Average disclosed round size is $281.8M (across 467 rounds with reported amounts).
Portfolio
368
Fund Size
$3.3B
Top Stage
Series B
Last 12 Mo
18
Team
Ankit KHEMKA
Managing Director, GCC Managing Director, Structuring & Execution
Aseem SOOD
Managing Director, Real Estate
Belinda TAN
Managing Director, Finance (Financial Management)
Benjamin HONIG
Managing Director, Europe
CHANG Yuliang
Managing Director, China
Eddy HO
Managing Director, Emerging Technologies
Ethan PARK
Managing Director, Asia Pacific (ex. China & India)
Franziska ZIMMERMANN
Managing Director, Sustainability
Grace GOH
Managing Director, Special Projects
Horace TING
Managing Director, Operations
Jason SUN Xianbing
Managing Director, China Chief Representative, Beijing
Johan DULAT
Head, Structuring & Execution Managing Director, Portfolio Development
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Tropic | Series C | $105M | Dec 2026 |
| BBoring Company | Series D | — | Sep 2026 |
 The Boring Company | Series D | — | Sep 2026 |
 Atomberg | Series C | $86M | Aug 2026 |
 Rize | Series B | $31M | Jul 2026 |
 Nearfield Instruments | Series D | $380M | Jun 2026 |
 TeraWatt Technology | Series C | — | Apr 2026 |
 Tropic | Series C | $105M | Mar 2026 |
| AAdvanced Machine Intelligence Labs | Seed | $1.0B | Mar 2026 |
| Tropic | Series C | $105M | Mar 2026 |
 Tropic Biosciences | Bridge | $105M | Mar 2026 |
 Rhoda AI: | Series D | — | Mar 2026 |
 PsiQuantum | Series C | — | Jan 2026 |
 Pasqal | Seed | — | Jan 2026 |
 CultFit | Series G | — | Jan 2026 |
 Cure.fit | Series G | — | Jan 2026 |
 Waterdrop | Series B | — | Jan 2026 |
| AAMI | Seed | $1.0B | Jan 2026 |
 Upscale Ai | Series A | $190M | Jan 2026 |
| AAlan SA | Unknown | $480M | Jan 2026 |
| MMedigate (Claroty) | Series F | $150M | Jan 2026 |
 ZhongJi InnoLight | Unknown | — | Jan 2026 |
 OneCard | Series D | — | Jan 2026 |
 NewMed | Unknown | $100M | Jan 2026 |
 D3 Bio | Series C | — | Dec 2025 |
Top Co-Investors
Last updated: 7 October 2026